Cargando…

A Therapeutic Pathway in Patients with Chronic Coronary Syndromes: Proposal for Optimization

There is uncertainty in cardiologists’ attitudes for prolonging dual antiplatelet therapy (DAPT) with ticagrelor 60 mg beyond 12 months in post-myocardial infarction (MI) patients. We aimed at characterizing the Italian cardiologists’ perceptions and needs in the management of such patients. Two con...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Caterina, Raffaele, Calabrò, Paolo, Campo, Gianluca, Rossini, Roberta, Giubilato, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028169/ https://www.ncbi.nlm.nih.gov/pubmed/35456184 http://dx.doi.org/10.3390/jcm11082091

Ejemplares similares

Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention
por: Giubilato, Simona, et al.
Publicado: (2023)

Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes
por: Cimmino, Giovanni, et al.
Publicado: (2017)

Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study
por: Fiocca, Luigi, et al.
Publicado: (2022)

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
por: Moisi, Mădălina Ioana, et al.
Publicado: (2020)

Association of Circulating Heme Oxygenase-1, Lipid Profile and Coronary Disease Phenotype in Patients with Chronic Coronary Syndrome
por: Caselli, Chiara, et al.
Publicado: (2021)

A Tailored Antithrombotic Approach for Patients with Atrial Fibrillation Presenting with Acute Coronary Syndrome and/or Undergoing PCI: A Case Series
por: Giubilato, Simona, et al.
Publicado: (2022)

Antiplatelet therapy in patients with acute coronary syndromes and thrombocytopaenia: awaiting for evidence
por: Liga, Riccardo, et al.
Publicado: (2021)

Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why?
por: Tonet, Elisabetta, et al.
Publicado: (2019)

De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?
por: Masiero, Giulia, et al.
Publicado: (2020)

Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease
por: Pavasini, Rita, et al.
Publicado: (2021)

Usefulness of SYNTAX score II in complex percutaneous coronary interventions in the setting of acute coronary syndrome
por: Salvatore, Azzarelli, et al.
Publicado: (2016)

Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease
por: Caracciolo, Alessandro, et al.
Publicado: (2022)

The Incremental Role of Coronary Computed Tomography in Chronic Coronary Syndromes
por: Baessato, Francesca, et al.
Publicado: (2020)

The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways
por: Bergamaschi, Luca, et al.
Publicado: (2023)

Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
por: Limbruno, Ugo, et al.
Publicado: (2020)

Editorial: Coronary epicardial and microvascular hemodynamics
por: Polimeni, Alberto, et al.
Publicado: (2022)

Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A Meta-Analysis
por: Bytyçi, Ibadete, et al.
Publicado: (2023)

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study
por: De Luca, Leonardo, et al.
Publicado: (2022)

Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndrome
por: Rotondo, John Charles, et al.
Publicado: (2021)

Chronic Abdominal Syndrome Due to Nervous Compression. Study of 100 Cases and Proposed Diagnostic-Therapeutic Algorithm
por: Lara, Francisco Javier Pérez, et al.
Publicado: (2015)

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways
por: Pelliccia, Francesco, et al.
Publicado: (2023)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Recommendations on Use of Biochemical Markers in Acute Coronary Syndrome: IFCC Proposals
por: Panteghini, Mauro
Publicado: (2003)

Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test
por: Zywicki, Viola, et al.
Publicado: (2022)

Immune-Inflammatory Activation in Acute Coronary Syndromes: A Look into the Heart of Unstable Coronary Plaque
por: Cimmino, Giovanni, et al.
Publicado: (2017)

Pollution and coronary risk: how much does it matter?
por: Muscente, Francesca, et al.
Publicado: (2022)

Optimizing the Management and Outcomes of Failed Back Surgery Syndrome: A Proposal of a Standardized Multidisciplinary Team Care Pathway
por: Gatzinsky, Kliment, et al.
Publicado: (2019)

In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome
por: Campioni, Diana, et al.
Publicado: (2013)

Clinical governance of patients with acute coronary syndromes
por: Leonardi, Sergio, et al.
Publicado: (2022)

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide
por: Soriano, Alessandra, et al.
Publicado: (2020)

Coronary Magnetic Resonance Angiography in Chronic Coronary Syndromes
por: Hajhosseiny, Reza, et al.
Publicado: (2021)

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome
por: Patti, Giuseppe, et al.
Publicado: (2017)

Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies
por: Pavasini, Rita, et al.
Publicado: (2021)

A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification
por: Tognetto, Alessia, et al.
Publicado: (2017)

Proposal for a new diagnostic-therapeutic algorithm in chronic rhinosinusitis with nasal polyps
por: Gelardi, Matteo, et al.
Publicado: (2023)

The importance of particular coronary collaterals’ pathway in acute coronary syndrome
por: Alhejily, Wesam A.
Publicado: (2015)

Determinants to optimize response to clopidogrel in acute coronary syndrome
por: Giusti, Betti, et al.
Publicado: (2010)

Optimal management of patients after acute coronary syndrome
por: Panattoni, Germana, et al.
Publicado: (2023)

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide
por: De Caterina, Raffaele, et al.
Publicado: (2017)

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome
por: Gabaldon-Perez, Ana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ppuh9vklceohhe47uulktl44lj